Genomic testing enables more personalised treatment decisions by identifying a broader range of genetic alterations in a single test. Access to Comprehensive Genomic Profiling (CGP) across Europe remains highly fragmented, with significant disparities in reimbursement, infrastructure, and integration into cancer care pathways, resulting in many patients missing out on effective targeted therapies.
On Wednesday, 9 July, the ECGP Coalition will gather panellists in a 1-hour session to discuss CGP in healthcare systems and the recently published ECGP recommendations developed by ECGP in collaboration with renowned independent experts and patient advocates within the Steering Group.
What to Expect:
- What is CGP, its value, and its untapped potential
- ECGP recommendations to improve access to CGP in Europe
- Best practice of CGP implementation in Germany and France
Speakers:
- Prof. Paul Hofman, IHU RespirERA, University Côte d’Azur
- Antonella Cardone, Cancer Patients Europe – CPE
- Prof. Albrecht Stenzinger, University Hospital Heidelberg (UKHD)
Moderator:
- Matias Olsen, EUCOPE
Leave a Reply